Back

Early glycemic changes after initiation of oral anti-diabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Pharmacotherapy of diabetes: from bench to bedside Antidiabetic Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Jonas Ghouse

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Doctor S. Park (Illkirch, FR)
Abstract Slides
Presentation thumbnail
Doctor H. Kondo (Yufu City, JP)
Abstract
Presentation thumbnail
Doctor C. Parco (Ibbenbueren, DE)
Abstract
Presentation thumbnail
Professor D. McGuire (Dallas, US)
Abstract
Presentation thumbnail
Professor C. Desouza (Omaha, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Pharmacotherapy of diabetes: from bench to bedside

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Absolute treatment effects of novel oral antidiabetic drugs on cardiovascular mortality and hospitalization for heart failure: a meta-analysis of digitalized individual patient outcomes
27 August 2022
thumbnail
Congress Presentation
High levels of small dense LDL cholesterol potentiate the risk of poor glycemic management for long-term prognosis in patients with stable coronary artery disease
1 September 2025
thumbnail
Congress Presentation
Stress hyperglycemia: a predictor of major adverse cardiac events in non-diabetic patients with acute heart failure
21 May 2023
thumbnail
Congress Presentation
Hemoglobin glycation index and in-hospital mortality after acute myocardial infarction in patients with/without diabetes: a prospective, nationwide, and multicenter registry
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources